Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AQST

Aquestive Therapeutics Q1 Earnings Call Highlights

Aquestive Therapeutics (NASDAQ:AQST) said it remains on track to resubmit its new drug application for Anaphylm, its epinephrine sublingual film for severe allergic reactions, in the third quarter of 2026, while reporting higher first-quarter revenue and a narrower net loss. On the company’s first-

MarketBeat · May 14

ARS Pharma Urges FDA To Delay Approval Of Aquestive's Allergic Reaction Treatment

ARS Pharmaceuticals Inc. (NASDAQ:SPRY) filed a petition Monday urging the FDA to delay approval of Aquestive Therapeutics Inc.'s (NASDAQ:AQST) experimental epinephrine treatment, citing safety, dosing, and real-world use concerns.

Benzinga · Sep 23, 2025

FDA Confirms Direct Review Path For Aquestive's Allergy Treatment

The U.S. Food and Drug Administration (FDA) on Thursday informed Aquestive Therapeutics, Inc. (NASDAQ:AQST) that an advisory committee meeting is not required for Anaphylm (dibutepinephrine) Sublingual Film.

Benzinga · Sep 4, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

3 'Strong Buy' Penny Stocks to Grab Now for More Gains

Investing in penny stocks offers the potential for substantial returns over time, but it's a high-stakes endeavor best suited for bold investors who are willing to embrace the risks.

Barchart · Aug 24, 2024

Delays to French trains and flights increased sharply last year

2022 was one of the worst years of the past decade for train and air travel in France, an official evaluation has found, with more trains and planes delayed than in any year since the Covid-19 pandemic.

Radio France Internationale · Jul 26, 2023

3 Smart Money Stocks to Invest in Today

Fears of an impending recession have kept the stock market volatile. Therefore, it could be wise to invest in quality stocks APi Group (APG), Amphastar Pharmaceuticals (AMPH), and Aquestive Therapeutics (AQST), which institutional investors hold significantly. Read on….

StockNews.com · May 30, 2023

Aquestive Therapeutics Reveals Favorable Data From Epinephrine Trial For Allergies

Aquestive Therapeutics Inc (NASDAQ:AQST) announced topline results from the first three arms of Part 3 of the EPIPHAST study for its AQST-109 epinephrine oral film for allergic reactions, including anaphylaxis. In the first three arms of Part 3, AQST-109 12 mg continued to show rapid absorption with favorable pharmacokinetics. The median time to…

Benzinga · Jun 16, 2022

Read news from The Economist, FT, and more,
with one subscription

Aquestive Therapeutics Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Aquestive Therapeutics's (NASDAQ:AQST) reported sales totaled $12.27 million. Despite a 54.33% increase in earnings, the company posted a loss of $13.22 million.

Benzinga · May 16, 2022

Aquestive's AQST-109 Receives Fast Track Tag For Allergic Reactions

The FDA has granted Fast Track Designation to Aquestive Therapeutics Inc's (NASDAQ: AQST) AQST-109 for allergic reactions. AQST-109 is an orally delivered epinephrine-based product candidate for the emergency treatment of allergic reactions, including anaphylaxis.

Benzinga · Mar 17, 2022

Looking Into Aquestive Therapeutics's Return On Capital Employed

Benzinga Pro data, Aquestive Therapeutics (NASDAQ:AQST) reported Q4 sales of $11.08 million. Earnings fell to a loss of $28.95 million, resulting in a 98.87% decrease from last quarter.

Benzinga · Mar 11, 2022

Aquestive Highlights Early Data From Allergy Treatment Candidate AQST-109 Study

Aquestive Therapeutics Inc (NASDAQ: AQST) announced

Benzinga · Feb 25, 2022

Coverage From

People

Sristi Suman JayaswalThe

216 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.